Sero-prevalence of Hepatitis B Virus Infection and Associated Factors among Mothers in Gondar town, North-west Ethiopia: Population based study

Share:
  • Articles
  • Submited: December 21, 2018
  • Published: April 17, 2019

Abstract

Background: Hepatitis B virus (HBV) is the main cause of serious liver disease. Factors that increase the risk of HBV infection include contact during child birth and different horizontal ways of transmission. The main aim of this study was to determine sero-prevalence of HBV and associated risk factors among mothers in Gondar town, Northwest Ethiopia

Downloads

Download data is not yet available.

References

  1. Ryder S, Beckingham I. ABC of diseases of liver, pancreas, and biliary system: Acute hepatitis. British Medical Journal. 2001; 322: 151-153.
  2. Gunn RA, Murray PJ, Ackers ML, Hardison WG, Margolis HS. Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sexual Transmitted Disease. 2001; 28(3):166–170.
  3. Lok A.; Chronic hepatitis B: National England Journal of Medical Science; 2002; 346:1682–1683.
  4. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiologic Reviews. 2006; 28 (1):112-125.
  5. Machado M, Leite M, Silvac M, Sérgio P, Laura L, Lampea E, et al. Usefulness of in-house PCR methods for hepatitis B virus DNA detection. Journal of Virological Methods. 2015; 223: 40–44.
  6. Tian Y, James OJ. Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma. Virologica. 2015; 30 (2): 85-91
  7. Pazienza V, Niro G, Fontana R, Vinciguerra M and Andriulli A. Advance in molecular diagnostic tools for hepatitis B virus detection. Clinical Chemistry Laboratory Medicine. 2013; 51(9): 1707–1717.
  8. Ouneissa R, Bahri O, Yahia A, Touzi H, Azouz M, Mami N, et al. Evaluation of PCR-RFLP in the Pre-S Region as Molecular Method for Hepatitis B Virus Genotyping. Hepatitis Monthly. 2013; 13(10): e11781.
  9. Liu C. and Kao J. Clinical Implications of Hepatitis B Virus Genotype. Hepatology. 2006; 3: 33-40.
  10. Chisari FV and Ferrari C. Heptitis B virus immunopathology. Immunopathology. 1995; 17: 261 81.
  11. Moradpour D and Ward SJ. Understanding hepatitis B virus infection. National England Journal of Medical Science. 1995; 33: 1092-1093.
  12. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. Journal of clinical gastroenterology. 2004; 38(10):S158-68.
  13. Seid M, Gelaw B, Assefa A; Sero-prevalence of HBV and HCV Infections among Pregnant Women Attending Antenatal Care Clinic at Dessie Referral Hospital, Ethiopia; Advances in Life Sciences and Health: 2014; 1(2):109-120.
  14. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN et al. Chronic hepatitis B virus infection in Asian countries. Journal of Gastroenterology and Hepatology. 2000; 15(12):1356-1361.
  15. Lamberth JR, Reddy SC, Pan JJ, Dasher KJ. Chronic hepatitis B infection in pregnancy. World Journal of Hepatology. 2015; 7(9):1233-1337.
  16. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis. 2004; 11(2):97-107.
  17. Alavian M, Masoud H, Asl A, Ali K, Lankarani B; Hepatitis B Virus Infection in Iran; Society for Information Display; 2008; 8(4): 281-294.
  18. Hwang E, Cheung R.; Global epidemiology of Hepatitis B virus (HBV) infection. North American Journal of Medical Sciences. 2011; 4 (01):7-13.
  19. Abebe A, Nokes D, Dejene A, Enquselassie F, Messele T, Cutts F. Sero epidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiology and Infection. 2003; 131 (01):757-770.
  20. Tsega E, Mengesha B, Hansson BG, Lindberg J, Nordenfelt E. Hepatitis A, B, and delta infection in Ethiopia: a serologic survey with demographic data. American Journal of Epidemiology. 1986; 123(2):344-51.
  21. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. Journal of Clinical Virology. 2005; 34:S1-3.
  22. Ageely H, Mahfouz MS, Gaffar A, Elmakki E, Elhassan I, Yasin AO, et al. Prevalence and Risk Factors of Hepatitis B Virus in Jazan Region, Saudi Arabia. Health. 2015; 7(04):459-465.
  23. Juszczyk J. Clinical course and consequences of hepatitis B infection. Vaccine. 2000; 18:S23-25.
  24. Gambarin-Gelwan M: Hepatitis B in Pregnancy. Clinics of Liver Disease. 2007; 11 (4):945-963.
  25. Tiruneh M. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, Northwest Ethiopia. Ethiopian Medical Journal. 2008; 46(4):359-66.
  26. Anaedobe CG, Fowotade A, Omoruyi CE, Bakare RA. Prevalence, socio-demographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria. The Pan African Medical Journal. 2015; 20: 406.
  27. Angound BM. Dzia AB. Boumba LA. Itoua C. Ahombo G. Moukassa D. et al. Prevalence of Serologic Markers and Risk Factors for Hepatitis B Virus among Pregnant Women in Brazzaville, Congo. International Journal of Science and Research. 2016; 5 (1): 1907-1912.
  28. Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B. Hepatology International. 2016; 10 (1):1-98.
  29. Agbede OO, Iseniyi JO, Kolawole MO, Ojuawo A. Risk factors and seroprevalence of hepatitis B surface antigenemia in mothers and their preschool age children in Ilorin, Nigeria. Therapy in Future Medicine. 2007; 4(1):67-72.
  30. Xeuatvongsa A, Komada K, Kitamura T, Vongphrachanh P, Pathammavong C, Phounphenghak K, et al. Chronic hepatitis B prevalence among children and mothers: results from a nationwide, population-based survey in Lao People's Democratic Republic. Public Library of Science One. 2014; 9(2):e88829.
  31. Rashid S.; Hepatitis B Virus Infection among Antenatal Clinic Attendees at the Muhimbili National Hospital, Seroprevalence and Associated Factors. African Journal; 2011; 1-8.
  32. Tegegne D, Desta K, Tegbaru B, Tilahun T. Seroprevalence and transmission of Hepatitis B virus among delivering women and their new born in selected health facilities, Addis Ababa, Ethiopia. Biomedical Center of Research Notes. 2014; 7(1): 239.
  33. Awole M, Gebre-Selassie S. Seroprevalence of HBsAg and its risk factors amoung pregnant women in Jimma, Southwest Ethiopia. Ethiopian Journal of Health Development. 2005; 19(1):45-50.
  34. Yohanes T, Zerdo Z, Chufamo N. Seroprevalence and Predictors of Hepatitis B Virus Infection among Pregnant Women Attending Routine Antenatal Care in Arba Minch Hospital, South Ethiopia. Hepatitis Research and Treatment. 2016; 1.e9290163.
  35. Zenebe Y, Mulu W, Yimer M, Abera B. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia. Biomedical Center of Infectious Diseases. 2014; 14(1):118.
  36. Molla S, Munshea A, Nibret E. Seroprevalence of hepatitis B surface a1ntigen and anti HCV antibody and its associated risk factors among pregnant women attending maternity ward of Felege Hiwot Referral Hospital, northwest Ethiopia. Virology Journal. 2015; 12 (1):204.
  37. Walle F, Asrat D, Alem A, Tadesse E, Desta K. Prevalence of hepatitis B surface antigen among pregnant women attending antenatal care service at Debre-Tabor Hospital, Northwest Ethiopia. Ethiopian Journal of Health Sciences. 2008; 17(1):13.
  38. Afzali H, Heravi MM, Moravveji SA, Poorrahnama M. Prevalence of Hepatitis B Surface Antigen in Pregnant Women in Beheshti Hospital of Kashan, Isfahan. Iranian Red Crescent Medical Journal. 2015; 17(7).
  39. Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O. The prevalence of hepatitis B and C viral infections among pregnant women. North American Journal of Medical Sciences. 2011; 3(5):238-241.
  40. Ibrahim IA, Pondei K. Hepatitis B and C Infection: should gynecological patients be routinely screened. International Journal of Medicine and Biomedical Research. 2014; 3(1):45-51.
  41. Onwuakor CE, Eze VC, Nwankwo IU, Iwu JO. Sero-prevalence of hepatitis B surface antigen (HBsAg) amongst pregnant women attending antenatal clinic at the Federal Medical Centre Umuahia, Abia State, Nigeria. American Journal of Public Health Research. 2014; 2(6):255-259.
  42. Abdallah TM, Mohamed MH, Ali AA. Seroprevalence and epidemiological factors of hepatitis B virus (HBV) infection in Eastern Sudan. International Journal of Medicine and Medical Sciences. 2011; 3 (7):239-41.
  43. Desalegn Z, Wassie L, Beyene HB, Mihret A, Ebstie YA. Hepatitis B and human immunodeficiency virus co-infection among pregnant women in resource-limited high endemic setting, Addis Ababa, Ethiopia. European Journal of Medical Research. 2016; 21(1):16.
  44. Abdi U, Seyoum B. Sero-Prevalence of Hepatitis B Virus Infections and Associated Factors Among Pregnant Women Attending Antenatal Clinic at Deder Hospital, Eastern Ethiopia. 2015; URI:http://hdl.handle.net/123456789/2588.
  45. Shamsuddin K, Marmuji LZ. Weighted analysis of prevalence and risk factors of hepatitis B infection among antenatal mothers in Ipoh. Singapore Medical Journal. 2010; 51(10):800.
  46. Bayo P, Ochola E, Oleo C, Mwaka AD. High prevalence of hepatitis B virus infection among pregnant women attending antenatal care, Northern Uganda. Biomedical Journal Open. 2014; 4(11):e005889.
  47. Yakasai IA, Ayyuba R, Abubakar IS, Ibrahim SA. Sero-prevalence of Hepatitis B Virus Infection and its Risk factors among Pregnant Women Attending Antenatal Clinic at Aminu Kano Teaching Hospital, Kano, Nigeria. Journal of Basic and Clinical Reproductive Sciences. 2012; 1 (1 and 2): 49-55.
  48. Dwivedi M, Misra SP, Misra V, Pandey A, Pant S, Singh R, et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian Journal of Gastroenterology. 2011; 30(2):66-71.
  49. Eke AC, Eke UA, Okafor CI, Ezebialu IU, Ogbuagu C. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virology Journal. 2011; 8(1):1.
  50. Utoo BT. Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria. African Health Sciences. 2013; 13(4):1139-43.
  51. Hatami H, Salehi M, Sanei E, Khosravi S, Alavian SM. Intra-familial Transmission of Hepatitis B virus Infection in Zahedan. Iranian Red Crescent Medical Journal. 2013; 15(1):4.
  52. Al-Shamahy H. Prevalence of hepatitis B surface antigen and risk factors of HBV infection in a sample of healthy mothers and their infants in Sanaa Yemen. Annals of Saudi Medicine. 2015; 20(5-6):464-467.
How to Cite
Geta, M., Ayalew, G., Yizengaw, E., Mihret, A., Aseffa, A., Howe, R., Moges, F., & Abate, E. (2019). Sero-prevalence of Hepatitis B Virus Infection and Associated Factors among Mothers in Gondar town, North-west Ethiopia: Population based study. Ethiopian Medical Journal. Retrieved from https://emjema.org/index.php/EMJ/article/view/1236

Send mail to Author


Send Cancel